Public Policy
Clinical Pharmacology & Therapeutics (2007) 82, 466–471; doi:10.1038/sj.clpt.6100334; published online 22 August 2007
The Emerging Role of Pharmacogenomics in Biologics
E Lacaná1, S Amur2, P Mummanneni2, H Zhao2 and F W Frueh2
- 1Office of Biotechnology Products, Division of Therapeutic Proteins, Center for Drugs Evaluation and Research, Bethesda, Maryland, USA
- 2Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
Correspondence: FW Frueh, (Felix.Frueh@fda.hhs.gov)
